v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (9,963) $ (7,816)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 8,124 3,430
Accrued interest on marketable securities, net 46 (279)
Stock-based compensation expense 17,310 16,093
Amortization of discount and debt issuance costs 548 192
Loss on impairment of intangible assets 0 1,655
Deferred taxes 210 (8,312)
Changes in operating assets and liabilities:    
Accounts receivable 59 (6,572)
Prepaid expenses and other assets (3,639) (5,416)
Accounts payable and accrued liabilities (15,740) (2,002)
Deferred costs (1,004) (158)
Deferred revenues (751) 3,521
Net cash used in operating activities (4,800) (5,664)
Cash flows from investing activities:    
Purchase of marketable securities (17,595) (21,883)
Proceeds from sales, maturities, and redemptions of marketable securities 15,950 9,900
Purchases of property and equipment (387) (485)
Capitalized software development costs (2,187) (1,446)
Acquisition of business, net of cash acquired 0 (375,499)
Net cash used in investing activities (4,219) (389,413)
Cash flows from financing activities:    
Payments on revolving loan (15,000) 0
Debt issuance costs paid 0 (779)
Proceeds from issuance of convertible senior notes 0 335,513
Proceeds from borrowing under revolving loan 0 60,000
Purchase of capped calls 0 (33,879)
Proceeds from stock option exercises 974 1,523
Net cash (used in) provided by financing activities (14,026) 362,378
Net decrease in cash and cash equivalents (23,045) (32,699)
Cash and cash equivalents, beginning of period 63,457 94,359
Cash and cash equivalents, end of period 40,412 61,660
Noncash Investing and Financing Items [Abstract]    
Accrued but unpaid debt issuance costs $ 0 $ 1,119